Vertex Pharmaceuticals, Inc. (VRTX) Posts Q4 EPS of 4c; Guides FY13 Sales

January 29, 2013 4:03 PM

Vertex Pharmaceuticals, Inc. (NASDAQ: VRTX) reported Q4 EPS of $0.04, $0.11 better than ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found